Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Bromodiphenhydramine (compound)


PubChem
Name: bromodiphenhydramine
PubChem Compound ID: 15736
Molecular formula: C17H21BrClNO
Molecular weight: 370.711 g/mol
Synonyms:
1808-12-4; 2-((4-Bromophenyl)phenylmethoxy)ethyl(dimethyl)ammonium chloride; Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochoride; Bromazine hydrochloride; EINECS 217-310-9; Ambodryl; Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochloride; Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochloride (9CI); ETHYLAMINE, 2-((p-BROMO-alpha-PHENYLBENZYL)OXY)-N,N-DIMETHYL-, HYDROCHLORIDE; 2-((p-Bromo-alpha-phenylbenzyl)oxy)-N,N-dimethylethylamine hydrochloride.
show more »
DrugBank
Identification
Name: bromodiphenhydramine
Name (isomeric): DB01237
Drug Type: small molecule
Synonyms:
Bromazine hydrochloride; Amodryl; Bromdiphenhydramine; Bromazine; Bromazin; Bromanautine; Bromdiphenhydramine hydrochloride; Bromodiphenhydramine hydrochloride; Ambodryl Hydrochloride; Bromdiphenylhydramine Hydrochloride
Brand: Bromo-Benzdryl, Histabromamine, Deserol, Neo-Benadryl, Bromo-Benadryl
Brand name mixture: Ambenyl Cough Syrup(Ammonium Chloride + Bromodiphenhydramine Hydrochloride + Codeine Phosphate + Diphenhydramine Hydrochloride + Potassium Guaiacol Sulphonate)
Category: Antihistamines
CAS number: 1808-12-4
Pharmacology
Indication: For management of symptoms related to hay fever and other types of allergy and used to help bring up phlegm, thin secretions, and make a cough productive.
Pharmacology:
Bromodiphenhydramine is an antihistamine of the ethanolamine class. Ethanolamine antihistamines have significant antimuscarinic activity and produce marked sedation in most patients. In addition to the usual allergic symptoms, the drug also treats irritant cough and nausea, vomiting, and vertigo associated with motion sickness. It also is used comm...
show more »
Mechanism of Action: Bromodiphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.
Absorption: Well absorbed in the digestive tract.
Protein binding: 96%
Biotransformation: Hepatic (cytochrome P-450 system); some renal.
Half Life: 1 to 4 hours
Toxicity: Signs of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, swelling of face, lips, tongue, or throat.
Affected organisms: Humans and other mammals
Interactions
Drug interaction:
TrospiumTrospium and Bromodiphenhydramine, two anticholinergics, may cause additive anticholinergic effects and enhanced adverse/toxic effects. Monitor for enhanced anticholinergic effects.
TriprolidineTriprolidine and Bromodiphenhydramine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Additive CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects.
TrimethobenzamideTrimethobenzamide and Bromodiphenhydramine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Monitor for enhanced anticholinergic effects.
TacrineThe therapeutic effects of the central acetylcholinesterase inhibitor, Tacrine, and/or the anticholinergic, Bromodiphenhydramine, may be reduced due to antagonism. The interaction may be beneficial when the anticholinergic action is a side effect. Monitor for decreased efficacy of both agents.

Targets


Transporters